CTY City Therapeutics, Inc. - Common Stock

—Mkt Cap: —P/E: —3d ago

City Therapeutics, Inc. operates as a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines by engineering RNAi trigger molecules. The company develops RNAi-based medicines using enginee…

Key Statistics

Company

Market Cap—

Enterprise Value261.94M USD

Revenue (TTM)14.34M USD

Gross Profit-66.02M USD

Net Income (TTM)-87.67M USD

Revenue/Share2.57 USD

Last Price—

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees75

CountryUS

Sector—

Industry—

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-3.16

EV/Revenue18.26

P/S78.61

P/B-0.90

EPS (TTM)—

EPS (Forward)—

52W Range

—

52W High—

52W Low—

Profitability

Gross Margin0.00%

Oper. Margin-804.20%

EBITDA Margin0.00%

Profit Margin0.00%

ROE—

ROA—

ROIC—

ROCE—

Growth

Revenue Growth14.00%

Earnings Growth—

Cash Flow & Leverage

Operating CF-77.67M USD

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt-112.57M USD

Net Debt/EBITDA1.36

Net Debt/FCF—

Balance Sheet

Debt/Equity45.87

Current Ratio2.71

Quick Ratio2.70

Book Value/Sh-24.91 USD

Cash/Share32.07 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.50.33M

Float3.09M

Insiders—

Institutions—

Technical

SMA 5022.40 USD

SMA 20022.40 USD

Beta—

S&P 52W Chg13.72%

Avg Vol (30d)—

Avg Vol (10d)1.41M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—